Parkside Financial Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $97.5K | Buy |
1,766
+168
| +11% | +$9.1K | 0.01% | 691 |
|
|
2025
Q4 | $78.4K | Buy |
1,598
+346
| +28% | +$16.1K | 0.01% | 789 |
|
|
2025
Q3 | $54K | Sell |
1,252
-43
| -3% | -$1.68K | ﹤0.01% | 907 |
|
|
2025
Q2 | $49.7K | Sell |
1,295
-111
| -8% | -$4.24K | 0.01% | 899 |
|
|
2025
Q1 | $54.5K | Buy |
1,406
+414
| +42% | +$15.2K | 0.01% | 807 |
|
|
2024
Q4 | $33.5K | Buy |
992
+818
| +470% | +$29.4K | ﹤0.01% | 937 |
|
|
2024
Q3 | $7.11K | Buy |
174
+66
| +61% | +$2.7K | ﹤0.01% | 1351 |
|
|
2024
Q2 | $4.16K | Hold |
108
| – | – | ﹤0.01% | 1412 |
|
|
2024
Q1 | $4.63K | Sell |
108
-240
| -69% | -$9.9K | ﹤0.01% | 1357 |
|
|
2023
Q4 | $12.9K | Buy |
348
+108
| +45% | +$3.88K | ﹤0.01% | 1090 |
|
|
2023
Q3 | $8.7K | Hold |
240
| – | – | ﹤0.01% | 1169 |
|
|
2023
Q2 | $8.55K | Sell |
240
-160
| -40% | -$5.74K | ﹤0.01% | 1173 |
|
|
2023
Q1 | $14.2K | Buy |
400
+160
| +67% | +$5.6K | ﹤0.01% | 983 |
|
|
2022
Q4 | $8.43K | Buy |
+240
| New | +$7.99K | ﹤0.01% | 1126 |
|
|
2022
Q3 | – | Sell |
-90
| Closed | -$5K | – | 1849 |
|
|
2022
Q2 | $5K | Sell |
90
-56
| -38% | -$3.09K | ﹤0.01% | 1227 |
|
|
2022
Q1 | $8K | Sell |
146
-1,984
| -93% | -$108K | ﹤0.01% | 1106 |
|
|
2021
Q4 | $117K | Hold |
2,130
| – | – | 0.03% | 333 |
|
|
2021
Q3 | $102K | Hold |
2,130
| – | – | 0.03% | 321 |
|
|
2021
Q2 | $106K | Sell |
2,130
-160
| -7% | -$7.69K | 0.03% | 321 |
|
|
2021
Q1 | $102K | Sell |
2,290
-1,502
| -40% | -$68.2K | 0.03% | 314 |
|
|
2020
Q4 | $174K | Hold |
3,792
| – | – | 0.05% | 211 |
|
|
2020
Q3 | $178K | Sell |
3,792
-1,696
| -31% | -$85K | 0.06% | 198 |
|
|
2020
Q2 | $280K | Buy |
5,488
+1,696
| +45% | +$87K | 0.09% | 160 |
|
|
2020
Q1 | $180K | Buy |
+3,792
| New | +$202K | 0.07% | 189 |
|
|
2018
Q2 | – | Sell |
-223
| Closed | -$11K | – | 1565 |
|
|
2018
Q1 | $11K | Hold |
223
| – | – | ﹤0.01% | 706 |
|
|
2017
Q4 | $10K | Hold |
223
| – | – | ﹤0.01% | 730 |
|
|
2017
Q3 | $11K | Hold |
223
| – | – | ﹤0.01% | 701 |
|
|
2017
Q2 | $12K | Hold |
223
| – | – | ﹤0.01% | 681 |
|
|
2017
Q1 | $12K | Buy |
+223
| New | +$11.3K | 0.01% | 651 |
|
|
2015
Q3 | – | Sell |
-5,141
| Closed | -$268K | – | 1073 |
|
|
2015
Q2 | $268K | Sell |
5,141
-505
| -9% | -$28.4K | 0.14% | 135 |
|
|
2015
Q1 | $326K | Buy |
5,646
+209
| +4% | +$12K | 0.17% | 118 |
|
|
2014
Q4 | $291K | Sell |
5,437
-925
| -15% | -$51.8K | 0.16% | 119 |
|
|
2014
Q3 | $365K | Sell |
6,362
-1,628
| -20% | -$99.8K | 0.22% | 102 |
|
|
2014
Q2 | $535K | Sell |
7,990
-1,159
| -13% | -$78.4K | 0.32% | 77 |
|
|
2014
Q1 | $611K | Hold |
9,149
| – | – | 0.38% | 68 |
|
|
2013
Q4 | $611K | Buy |
+9,149
| New | +$593K | 0.41% | 62 |
|
Other funds holding GSK
JEST
Parkside Financial Bank & Trust's GSK Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its GSK (GSK) stake by 11% in Q1 2026, buying an estimated $9.1K and bringing the position to 1,766 shares worth $97.5K. The position accounts for 0.01% of the portfolio, ranked #691.
Parkside Financial Bank & Trust first reported a position in GSK in Q4 2013 and has held it in 36 quarters since. The position peaked at $611K in Q1 2014. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Parkside Financial Bank & Trust held 1,766 shares of GSK worth $97.5K as of Q1 2026.
- Parkside Financial Bank & Trust bought 168 GSK shares in Q1 2026, an estimated $9.1K.
- GSK made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #691 holding.
- Parkside Financial Bank & Trust first reported a position in GSK in Q4 2013 and has held it in 36 quarters since.
- Parkside Financial Bank & Trust's GSK position peaked at $611K in Q1 2014.
- 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.